Array Biopharma Inc (NASDAQ:ARRY)

17.93
Delayed Data
As of Jun 15
 -0.07 / -0.39%
Today’s Change
7.15
Today|||52-Week Range
18.78
+40.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues42.1M51.9M137.9M150.9M
 
 
 
 
 
Cost of Goods Sold41.5M40.7M21.6M33.3M
 
 
 
 
 
Depreciation And Amortization4.5M3.7M1.5M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income-3.9M7.5M114.7M115.5M
 
 
 
 
 
General Expenses68.9M85.9M196.9M217.5M
 
 
 
 
 
Research And Development47.6M54.4M160.7M178.2M
 
 
 
 
 
Total Operating Expenses114.9M130.3M220.1M252.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-72.8M-78.4M-82.2M-102.1M
 
 
 
 
 
Extraordinary Credit0.0080.0M0.000.00
 
 
Extraordinary Charge-2.8M--0.00-4.1M
 
 
 
Interest Expense On Debt9.7M10.2M10.9M12.3M
 
 
 
 
 
Other Expenses0.0017.9M0.00897.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-85.3M9.4M-92.8M-116.8M
 
 
 
 
 
Net Income-85.3M9.4M-92.8M-116.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS123.4M136.7M143.0M163.2M
 
 
 
 
 
Shares To Calculate EPS Diluted123.4M141.7M143.0M163.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.69$0.07-$0.65-$0.72
 
 
 
 
 
EPS Diluted-$0.69$0.07-$0.65-$0.72